BACTERIOPHAGES IN RECURRENT URINARY TRACT INFECTION IN PATIENTS WITH PAINFUL BLADDER SYNDROME /INTERSTITIAL CYSTITIS. CLINICAL CASES


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

At the present stage, when managing patients with painful bladder syndrome/ interstitial cystitis (PBS/IC), one should be prepared for infectious complications arising during treatment in the form of recurrent urinary tract infection. The article presents clinical observations of successful bacteriophage treatment of patients suffering from painful bladder syndrome/interstitial cystitis with recurrent urinary tract infection.

Texto integral

Acesso é fechado

Sobre autores

D. Pushkar

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: pushkardm@mail.ru
Academician of the Russian Academy of Sciences, Head of the Urology Department Moscow, Russia

A. Zaitsev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: zaitcevandrew@mail.ru
Sc. D. in Medicine, Urology Department Moscow, Russia

O. Arefieva

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: oksadoc@yandex.ru
Ph. D. in Medicine, assistant, Urology Department Moscow, Russia

A. Vasilyev

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: alexvasilyev@me.com
Ph. D. in Medicine, Assistant Professor, Urology Department Moscow, Russia

N. Sazonova

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: kalininatalia06@gmail.com
resident physician Moscow, Russia

V. Melnikov

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: vladimir-m95@mail.ru
resident physician Moscow, Russia

Bibliografia

  1. Зайцев А.В., Шаров М.Н., Арефьева О.А., Пушкарь Д.Ю. Синдром болезненного мочевого пузыря/ интерстициальный цистит: факторы прогноза клинического течения заболевания. Вестник урологии. 2018;6(3):26-35.
  2. Salmond G.P., Fineran P.C. A century of the phage: past, present and future. Nat. Rev. Microbiol. 2015;13:777-786. doi: 10.1038/nrmicro3564.
  3. Garretto A., Miller-Ensminger T., Wolfe A.J., Putonti C. Bacteriophages of the lower urinary tract. Nat. Rev. Urol. 2019;16:422-432. doi: 10.1038/s41585-019-0192-4.
  4. Васильев А.О., Зайцев А.В., Ширяев А.А., Ким Ю.А., Сазонова Н.А., Пушкарь Д.Ю. Бактериофаготерапия в лечении пожилых пациентов с инфекционными осложнениями нижних мочевых путей. Клиническая геронтология. 2020;26(1-2): 22-28.
  5. Перепанова Т.С., Меринов Д.С., Казаченко А.В., Хазан П.Л., Малова Ю.А. Бактериофаготерапия урологической инфекции. Урология. 2020; 106-114.
  6. Liu D., Van Belleghem J.D.,de Vries C.R.,Burgener E., Chen Q., Manasherob R., Aronson J.R., Amanatullah D.F., Tamma P.D., Suh G.A. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies. Viruses. 2021;13. doi: 10.3390/v13071268. PMID: 34209836
  7. Белобородова Н.В., Гречко А.В., Гуркова М.М., Зурабов А.Ю., Зурабов Ф.М., Кузовлев А.Н., Меглей А.Ю., Петрова М.В., Попова В.М., Редкин И.В., Сергеев Н.И., Черневская Е.А., Юрьев М.Ю., Яковлев А.А. Адаптивная фаготерапия пациентов с рецидивирующими пневмониями (пилотное исследование). Общая реаниматология. 2021;17(6):4-14). https://doi.org/10.15360/1813-9779-2021-6-4-14
  8. Leitner L., Ujmajuridze A., Chanishvili N., Goderdzishvili M., Chkonia I., Rigvava S., Chkhotua A., Changashvili G., McCallin S., Schneider M.P., Liechti M.D., Mehnert U., Bachmann L.M., Sybesma W., Kessler T.M.Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. Lancet Infect Dis. 2021;21(3):427- 436. doi: 10.1016/S1473-3099(20)30330-3.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2022